LivaNova LIVN Insider Ownership

Updated Oct 5, 2026

Over the past 12 months, LivaNova insiders sold $1.05 million of stock on the open market (13.38K shares) and made no open-market purchases.

• A count shows 3 insiders selling LIVN stock on the open market over the past 12 months and none buying.
• The largest open-market sales of LIVN in the past 12 months were by Francesco Bianchi (Director), totaling $637,148 (8.15K shares), most recently on September 10, 2026.
• Outside the open market, LivaNova insiders acquired 118.33K shares through option exercises and conversions and gave up 44.13K shares to cover taxes or exercise prices over the past 12 months.
• According to Business Quant data, insiders at LivaNova reported 224.49K shares in total in their latest Form 4 filings, down 3.21% from 231.94K shares at the end of Q2 2026 and up 10.57% from 203.02K shares at the end of Q3 2025.
• All of the 224.49K shares held by LivaNova insiders are held directly, none through trusts, partnerships or other entities.
• Business Quant counts 17 insiders with holdings in LivaNova stock, among the officers, directors and 10% owners who have filed a Form 4 in the past two years.
• LIVN's three largest insider shareholders, per their latest Form 4 filings, are Alex Shvartsburg (Chief Financial Officer, 44.65K shares), William A. Kozy (Director, 37.57K shares) and Stephanie Bolton (President, Global Epilepsy, 22.19K shares).
• The largest insider, Alex Shvartsburg, holds 19.89% of LIVN's insider total.
• Over the past 12 months, 18 insiders reported transactions in LivaNova stock in 28 Form 4 filings.
• The insider data for LIVN reflects Form 4 filings through September 16, 2026.